Three frequently used human esophageal adenocarcinoma cell lines used for research were confirmed as being from other tumor types, according to a brief communication published online January 14 in the Journal of the National Cancer Institute. Two of the cell lines have been used in 11 U.S. patents and more than 100 published studies. The 13 established esophageal adenocarcinoma cell lines are important because of the limited availability of patient samples and animal models. To determine the authenticity of all the available cell lines, Winand N.M. Dinjens, Ph.D... 
More...
More...